{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:47:46Z","timestamp":1792676866738,"version":"4.5.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CH 1862\/3-1 to AC"],"award-info":[{"award-number":["CH 1862\/3-1 to AC"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013209","name":"Hellenic Foundation for Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002957","name":"Technische Universit\u00e4t Dresden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Obes Rep"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>\n                           <jats:italic>Purpose of the Review<\/jats:italic>\n                        <\/jats:title>\n                <jats:p>Mitochondrial dysfunction has long been proposed to play a crucial role in the pathogenesis of a considerable number of disorders, such as neurodegeneration, cancer, cardiovascular, and metabolic disorders, including obesity-related insulin resistance and non-alcoholic fatty liver disease (NAFLD). Mitochondria are highly dynamic organelles that undergo functional and structural adaptations to meet the metabolic requirements of the cell. Alterations in nutrient availability or cellular energy needs can modify their formation through biogenesis and the opposite processes of fission and fusion, the fragmentation, and connection of mitochondrial network areas respectively. Herein, we review and discuss the current literature on the significance of mitochondrial adaptations in obesity and metabolic dysregulation, emphasizing on the role of hepatocyte mitochondrial flexibility in obesity and NAFLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>\n                           <jats:italic>Recent Findings<\/jats:italic>\n                        <\/jats:title>\n                <jats:p>Accumulating evidence suggests the involvement of mitochondrial morphology and bioenergetics dysregulations to the emergence of NAFLD and its progress to non-alcoholic steatohepatitis (NASH).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>\n                           <jats:italic>Summary<\/jats:italic>\n                        <\/jats:title>\n                <jats:p>Most relevant data suggests that changes in liver mitochondrial dynamics and bioenergetics hold a key role in the pathogenesis of NAFLD. During obesity and NAFLD, oxidative stress occurs due to the excessive production of ROS, leading to mitochondrial dysfunction. As a result, mitochondria become incompetent and uncoupled from respiratory chain activities, further promoting hepatic fat accumulation, while leading to liver inflammation, insulin resistance, and disease\u2019s deterioration. Elucidation of the mechanisms leading to dysfunctional mitochondrial activity of the hepatocytes during NAFLD is of predominant importance for the development of novel therapeutic approaches towards the treatment of this metabolic disorder.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s13679-022-00473-1","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T18:02:42Z","timestamp":1651514562000},"page":"126-143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7987-9665","authenticated-orcid":false,"given":"Aigli-Ioanna","family":"Legaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6113-9255","authenticated-orcid":false,"given":"Ioannis I.","family":"Moustakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5411-9969","authenticated-orcid":false,"given":"Michalina","family":"Sikorska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-943X","authenticated-orcid":false,"given":"Grigorios","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6249-2504","authenticated-orcid":false,"given":"Rallia-Iliana","family":"Velliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7039-4223","authenticated-orcid":false,"given":"Antonios","family":"Chatzigeorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"473_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fcell.2015.00040","volume":"3","author":"C Auger","year":"2015","unstructured":"Auger C, Alhasawi A, Contavadoo M, Appanna VD. Dysfunctional mitochondrial bioenergetics and the pathogenesis of hepatic disorders. Front Cell Dev Biol. 2015;3:40. https:\/\/doi.org\/10.3389\/fcell.2015.00040.","journal-title":"Front Cell Dev Biol"},{"key":"473_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3748\/wjg.14.193","volume":"14","author":"Y Wei","year":"2008","unstructured":"Wei Y, Rector RS, Thyfault JP, Ibdah JA. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol. 2008;14:193\u20139. https:\/\/doi.org\/10.3748\/wjg.14.193.","journal-title":"World J Gastroenterol"},{"key":"473_CR3","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.bbadis.2017.07.006","volume":"1863","author":"C Auger","year":"2017","unstructured":"Auger C, Sivayoganathan T, Abdullahi A, Parousis A, Jeschke MG. Hepatic mitochondrial bioenergetics in aged C57BL\/6 mice exhibit delayed recovery from severe burn injury. Biochim Biophys Acta Mol Basis Dis. 2017;1863:2705\u201314. https:\/\/doi.org\/10.1016\/j.bbadis.2017.07.006.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"473_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/387626","volume":"2012","author":"D Degli Esposti","year":"2012","unstructured":"Degli Esposti D, Hamelin J, Bosselut N, Saffroy R, Sebagh M, Pommier A, Martel C, Lemoine A. Mitochondrial roles and cytoprotection in chronic liver injury. Biochem Res Int. 2012;2012: 387626. https:\/\/doi.org\/10.1155\/2012\/387626.","journal-title":"Biochem Res Int"},{"key":"473_CR5","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1126\/science.1219855","volume":"337","author":"RJ Youle","year":"2012","unstructured":"Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science. 2012;337:1062\u20135. https:\/\/doi.org\/10.1126\/science.1219855.","journal-title":"Science"},{"key":"473_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.biocel.2017.12.019","volume":"95","author":"ICM Simoes","year":"2018","unstructured":"Simoes ICM, Fontes A, Pinton P, Zischka H, Wieckowski MR. Mitochondria in non-alcoholic fatty liver disease. Int J Biochem Cell Biol. 2018;95:93\u20139. https:\/\/doi.org\/10.1016\/j.biocel.2017.12.019.","journal-title":"Int J Biochem Cell Biol"},{"key":"473_CR7","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hep.23280","volume":"51","author":"E Fabbrini","year":"2010","unstructured":"Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679\u201389. https:\/\/doi.org\/10.1002\/hep.23280.","journal-title":"Hepatology"},{"key":"473_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1210\/er.2017-00111","volume":"38","author":"MW Schwartz","year":"2017","unstructured":"Schwartz MW, Seeley RJ, Zeltser LM, Drewnowski A, Ravussin E, Redman LM, Leibel RL. Obesity pathogenesis: an endocrine society scientific statement. Endocr Rev. 2017;38:267\u201396. https:\/\/doi.org\/10.1210\/er.2017-00111.","journal-title":"Endocr Rev"},{"key":"473_CR9","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jhep.2005.03.004","volume":"42","author":"D Pessayre","year":"2005","unstructured":"Pessayre D, Fromenty B. NASH: a mitochondrial disease. J Hepatol. 2005;42:928\u201340. https:\/\/doi.org\/10.1016\/j.jhep.2005.03.004.","journal-title":"J Hepatol"},{"key":"473_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/obr.12407","volume":"17","author":"L Li","year":"2016","unstructured":"Li L, Liu DW, Yan HY, Wang ZY, Zhao SH, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17:510\u20139. https:\/\/doi.org\/10.1111\/obr.12407.","journal-title":"Obes Rev"},{"key":"473_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism. 2019;92:82\u201397. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.014.","journal-title":"Metabolism"},{"key":"473_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081386","volume":"417","author":"MP Murphy","year":"2009","unstructured":"Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417:1\u201313. https:\/\/doi.org\/10.1042\/BJ20081386.","journal-title":"Biochem J"},{"key":"473_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1712","volume":"11","author":"SE Weinberg","year":"2015","unstructured":"Weinberg SE, Chandel NS. Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol. 2015;11:9\u201315. https:\/\/doi.org\/10.1038\/nchembio.1712.","journal-title":"Nat Chem Biol"},{"key":"473_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1085\/jgp.201210772","volume":"139","author":"MA Aon","year":"2012","unstructured":"Aon MA, Stanley BA, Sivakumaran V, Kembro JM, O\u2019Rourke B, Paolocci N, Cortassa S. Glutathione\/thioredoxin systems modulate mitochondrial H2O2 emission: an experimental-computational study. J Gen Physiol. 2012;139:479\u201391. https:\/\/doi.org\/10.1085\/jgp.201210772.","journal-title":"J Gen Physiol"},{"key":"473_CR15","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nrm3013","volume":"11","author":"B Westermann","year":"2010","unstructured":"Westermann B. Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol. 2010;11:872\u201384. https:\/\/doi.org\/10.1038\/nrm3013.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"473_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/ars.2012.4779","volume":"19","author":"CA Galloway","year":"2013","unstructured":"Galloway CA, Yoon Y. Mitochondrial morphology in metabolic diseases. Antioxid Redox Signal. 2013;19:415\u201330. https:\/\/doi.org\/10.1089\/ars.2012.4779.","journal-title":"Antioxid Redox Signal"},{"key":"473_CR17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s42255-019-0124-x","volume":"1","author":"S Seitz","year":"2019","unstructured":"Seitz S, Kwon Y, Hartleben G, J\u00fclg J, Sekar R, Krahmer N, Najafi B, Loft A, Gancheva S, Stemmer K, Feuchtinger A, Hrabe de Angelis M, M\u00fcller TD, Mann M, Bl\u00fcher M, Roden M, Berriel Diaz M, Behrends C, Gilleron J, Herzig S, Zeigerer A. Hepatic Rab24 controls blood glucose homeostasis via improving mitochondrial plasticity. Nat Metab. 2019;1:1009\u201326. https:\/\/doi.org\/10.1038\/s42255-019-0124-x.","journal-title":"Nat Metab"},{"key":"473_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tem.2015.12.001","volume":"27","author":"T Wai","year":"2016","unstructured":"Wai T, Langer T. Mitochondrial dynamics and metabolic regulation. Trends Endocrinol Metab. 2016;27:105\u201317. https:\/\/doi.org\/10.1016\/j.tem.2015.12.001.","journal-title":"Trends Endocrinol Metab"},{"key":"473_CR19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.cmet.2013.03.002","volume":"17","author":"M Liesa","year":"2013","unstructured":"Liesa M, Shirihai OS. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 2013;17:491\u2013506. https:\/\/doi.org\/10.1016\/j.cmet.2013.03.002.","journal-title":"Cell Metab"},{"key":"473_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41419-020-2429-9","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zhang Y, Chang X, Zhang X. Imbalance in mitochondrial dynamics induced by low PGC-1alpha expression contributes to hepatocyte EMT and liver fibrosis. Cell Death Dis. 2020;11:226. https:\/\/doi.org\/10.1038\/s41419-020-2429-9.","journal-title":"Cell Death Dis"},{"key":"473_CR21","first-page":"190","volume":"11","author":"Y Krishnasamy","year":"2019","unstructured":"Krishnasamy Y, Gooz M, Li L, Lemasters JJ, Zhong Z. Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice. International journal of physiology, pathophysiology and pharmacology. 2019;11:190\u2013204.","journal-title":"International journal of physiology, pathophysiology and pharmacology"},{"key":"473_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/hep.27420","volume":"61","author":"L Wang","year":"2015","unstructured":"Wang L, Liu X, Nie J, Zhang J, Kimball SR, Zhang H, Zhang WJ, Jefferson LS, Cheng Z, Ji Q, Shi Y. ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis. Hepatology. 2015;61:486\u201396. https:\/\/doi.org\/10.1002\/hep.27420.","journal-title":"Hepatology"},{"key":"473_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41419-017-0136-y","volume":"9","author":"L Pang","year":"2018","unstructured":"Pang L, Liu K, Liu D, Lv F, Zang Y, Xie F, Yin J, Shi Y, Wang Y, Chen D. Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease. Cell Death Dis. 2018;9:90. https:\/\/doi.org\/10.1038\/s41419-017-0136-y.","journal-title":"Cell Death Dis"},{"key":"473_CR24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41374-018-0177-6","volume":"99","author":"NP Zhang","year":"2019","unstructured":"Zhang NP, Liu XJ, Xie L, Shen XZ, Wu J. Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis. Lab Invest. 2019;99:749\u201363. https:\/\/doi.org\/10.1038\/s41374-018-0177-6.","journal-title":"Lab Invest"},{"key":"473_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ab.2017.01.018","volume":"529","author":"L Valkovic","year":"2017","unstructured":"Valkovic L, Chmelik M, Krssak M. In-vivo(31)P-MRS of skeletal muscle and liver: a way for non-invasive assessment of their metabolism. Anal Biochem. 2017;529:193\u2013215. https:\/\/doi.org\/10.1016\/j.ab.2017.01.018.","journal-title":"Anal Biochem"},{"key":"473_CR26","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2337\/dc10-1076","volume":"34","author":"AI Schmid","year":"2011","unstructured":"Schmid AI, Szendroedi J, Chmelik M, Krssak M, Moser E, Roden M. Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care. 2011;34:448\u201353. https:\/\/doi.org\/10.2337\/dc10-1076.","journal-title":"Diabetes Care"},{"key":"473_CR27","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1126\/science.1082889","volume":"300","author":"KF Petersen","year":"2003","unstructured":"Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003;300:1140\u20132. https:\/\/doi.org\/10.1126\/science.1082889.","journal-title":"Science"},{"key":"473_CR28","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1259\/0007-1285-59-703-695","volume":"59","author":"RD Oberhaensli","year":"1986","unstructured":"Oberhaensli RD, Galloway GJ, Taylor DJ, Bore PJ, Radda GK. Assessment of human liver metabolism by phosphorus-31 magnetic resonance spectroscopy. Br J Radiol. 1986;59:695\u20139. https:\/\/doi.org\/10.1259\/0007-1285-59-703-695.","journal-title":"Br J Radiol"},{"key":"473_CR29","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1572-0241.2003.07221.x","volume":"98","author":"S Nair","year":"2003","unstructured":"Nair S, V PC, Arnold C and Diehl AM,. Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals. Am J Gastroenterol. 2003;98:466\u201370. https:\/\/doi.org\/10.1111\/j.1572-0241.2003.07221.x.","journal-title":"Am J Gastroenterol"},{"key":"473_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.clnu.2015.04.001","volume":"35","author":"SJ Bawden","year":"2016","unstructured":"Bawden SJ, Stephenson MC, Ciampi E, Hunter K, Marciani L, Macdonald IA, Aithal GP, Morris PG, Gowland PA. Investigating the effects of an oral fructose challenge on hepatic ATP reserves in healthy volunteers: a (31)P MRS study. Clin Nutr. 2016;35:645\u20139. https:\/\/doi.org\/10.1016\/j.clnu.2015.04.001.","journal-title":"Clin Nutr"},{"key":"473_CR31","doi-asserted-by":"publisher","first-page":"E405","DOI":"10.1152\/ajpendo.00057.2013","volume":"305","author":"CN Adjeitey","year":"2013","unstructured":"Adjeitey CN, Mailloux RJ, Dekemp RA, Harper ME. Mitochondrial uncoupling in skeletal muscle by UCP1 augments energy expenditure and glutathione content while mitigating ROS production. Am J Physiol Endocrinol Metab. 2013;305:E405\u201315. https:\/\/doi.org\/10.1152\/ajpendo.00057.2013.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"473_CR32","doi-asserted-by":"publisher","first-page":"2101562","DOI":"10.1155\/2018\/2101562","volume":"2018","author":"M El-Hafidi","year":"2018","unstructured":"El-Hafidi M, Franco M, Ramirez AR, Sosa JS, Flores JAP, Acosta OL, Salgado MC, Cardoso-Saldana G. Glycine increases insulin sensitivity and glutathione biosynthesis and protects against oxidative stress in a model of sucrose-induced insulin resistance. Oxid Med Cell Longev. 2018;2018:2101562. https:\/\/doi.org\/10.1155\/2018\/2101562.","journal-title":"Oxid Med Cell Longev"},{"key":"473_CR33","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.biocel.2009.03.013","volume":"41","author":"E Gnaiger","year":"2009","unstructured":"Gnaiger E. Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. Int J Biochem Cell Biol. 2009;41:1837\u201345. https:\/\/doi.org\/10.1016\/j.biocel.2009.03.013.","journal-title":"Int J Biochem Cell Biol"},{"key":"473_CR34","doi-asserted-by":"publisher","first-page":"E715","DOI":"10.1152\/ajpendo.00475.2015","volume":"310","author":"E Ojuka","year":"2016","unstructured":"Ojuka E, Andrew B, Bezuidenhout N, George S, Maarman G, Madlala HP, Mendham A, Osiki PO. Measurement of beta-oxidation capacity of biological samples by respirometry: a review of principles and substrates. Am J Physiol Endocrinol Metab. 2016;310:E715\u201323. https:\/\/doi.org\/10.1152\/ajpendo.00475.2015.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"473_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.693997","volume":"8","author":"E Grossini","year":"2021","unstructured":"Grossini E, Garhwal DP, Calamita G, Romito R, Rigamonti C, Minisini R, Smirne C, Surico D, Bellan M, Pirisi M. Exposure to plasma from non-alcoholic fatty liver disease patients affects hepatocyte viability, generates mitochondrial dysfunction, and modulates pathways involved in fat accumulation and inflammation. Front Med (Lausanne). 2021;8: 693997. https:\/\/doi.org\/10.3389\/fmed.2021.693997.","journal-title":"Front Med (Lausanne)"},{"key":"473_CR36","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1002\/hep.23927","volume":"52","author":"S Sookoian","year":"2010","unstructured":"Sookoian S, Rosselli MS, Gemma C, Burgue\u00f1o AL, Fern\u00e1ndez Gianotti T, Casta\u00f1o GO, Pirola CJ. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator\u2013activated receptor \u03b3 coactivator 1\u03b1 promoter. Hepatology. 2010;52:1992\u20132000. https:\/\/doi.org\/10.1002\/hep.23927.","journal-title":"Hepatology"},{"key":"473_CR37","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1136\/gutjnl-2012-302962","volume":"62","author":"CJ Pirola","year":"2013","unstructured":"Pirola CJ, Gianotti TF, Burgue\u00f1o AL, Rey-Funes M, Loidl CF, Mallardi P, Martino JS, Casta\u00f1o GO, Sookoian S. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease. Gut. 2013;62:1356\u201363. https:\/\/doi.org\/10.1136\/gutjnl-2012-302962.","journal-title":"Gut"},{"key":"473_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molmet.2019.11.015","volume":"32","author":"J Stevanovic","year":"2020","unstructured":"Stevanovic J, Beleza J, Coxito P, Ascensao A, Magalhaes J. Physical exercise and liver \u201cfitness\u201d: role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease. Mol Metab. 2020;32:1\u201314. https:\/\/doi.org\/10.1016\/j.molmet.2019.11.015.","journal-title":"Mol Metab"},{"key":"473_CR39","doi-asserted-by":"publisher","first-page":"G632","DOI":"10.1152\/ajpgi.00182.2014","volume":"307","author":"CA Galloway","year":"2014","unstructured":"Galloway CA, Lee H, Brookes PS, Yoon Y. Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease. American journal of physiology. Gastrointestinal and liver physiology. 2014;307:G632\u201341. https:\/\/doi.org\/10.1152\/ajpgi.00182.2014.","journal-title":"Gastrointestinal and liver physiology"},{"key":"473_CR40","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.7150\/thno.21400","volume":"7","author":"J Du","year":"2017","unstructured":"Du J, Zhang X, Han J, Man K, Zhang Y, Chu ESH, Nan Y, Yu J. Pro-inflammatory CXCR3 impairs mitochondrial function in experimental non-alcoholic steatohepatitis. Theranostics. 2017;7:4192\u2013203. https:\/\/doi.org\/10.7150\/thno.21400.","journal-title":"Theranostics"},{"key":"473_CR41","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.bbrc.2019.04.069","volume":"514","author":"F Gong","year":"2019","unstructured":"Gong F, Gao L, Ding T. IDH2 protects against nonalcoholic steatohepatitis by alleviating dyslipidemia regulated by oxidative stress. Biochem Biophys Res Commun. 2019;514:593\u2013600. https:\/\/doi.org\/10.1016\/j.bbrc.2019.04.069.","journal-title":"Biochem Biophys Res Commun"},{"key":"473_CR42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41419-018-0292-8","volume":"9","author":"M Piacentini","year":"2018","unstructured":"Piacentini M, Baiocchini A, Del Nonno F, Melino G, Barlev NA, Rossin F, D\u2019Eletto M, Falasca L. Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2. Cell Death Dis. 2018;9:257\u2013257. https:\/\/doi.org\/10.1038\/s41419-018-0292-8.","journal-title":"Cell Death Dis"},{"key":"473_CR43","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1053\/gast.2001.23256","volume":"120","author":"AJ Sanyal","year":"2001","unstructured":"Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120:1183\u201392. https:\/\/doi.org\/10.1053\/gast.2001.23256.","journal-title":"Gastroenterology"},{"issue":"595\u2013617","key":"473_CR44","doi-asserted-by":"publisher","first-page":"x","DOI":"10.1016\/j.cld.2004.04.009","volume":"8","author":"SH Caldwell","year":"2004","unstructured":"Caldwell SH, Chang CY, Nakamoto RK, Krugner-Higby L. Mitochondria in nonalcoholic fatty liver disease. Clin Liver Dis. 2004;8(595\u2013617):x. https:\/\/doi.org\/10.1016\/j.cld.2004.04.009.","journal-title":"Clin Liver Dis"},{"key":"473_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092753","volume":"9","author":"L Lionetti","year":"2014","unstructured":"Lionetti L, Mollica MP, Donizzetti I, Gifuni G, Sica R, Pignalosa A, Cavaliere G, Gaita M, De Filippo C, Zorzano A, Putti R. High-lard and high-fish-oil diets differ in their effects on function and dynamic behaviour of rat hepatic mitochondria. PLoS ONE. 2014;9: e92753. https:\/\/doi.org\/10.1371\/journal.pone.0092753.","journal-title":"PLoS ONE"},{"key":"473_CR46","doi-asserted-by":"publisher","first-page":"8238","DOI":"10.1074\/jbc.RA118.004415","volume":"294","author":"S Mazumder","year":"2019","unstructured":"Mazumder S, De R, Debsharma S, Bindu S, Maity P, Sarkar S, Saha SJ, Siddiqui AA, Banerjee C, Nag S, Saha D, Pramanik S, Mitra K, Bandyopadhyay U. Indomethacin impairs mitochondrial dynamics by activating the PKCzeta-p38-DRP1 pathway and inducing apoptosis in gastric cancer and normal mucosal cells. J Biol Chem. 2019;294:8238\u201358. https:\/\/doi.org\/10.1074\/jbc.RA118.004415.","journal-title":"J Biol Chem"},{"key":"473_CR47","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fendo.2017.00296","volume":"8","author":"PM Herst","year":"2017","unstructured":"Herst PM, Rowe MR, Carson GM, Berridge MV. Functional mitochondria in health and disease. Front Endocrinol (Lausanne). 2017;8:296. https:\/\/doi.org\/10.3389\/fendo.2017.00296.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"473_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/482582","volume":"2015","author":"FM da Cunha","year":"2015","unstructured":"da Cunha FM, Torelli NQ, Kowaltowski AJ. Mitochondrial retrograde signaling: triggers, pathways, and outcomes. Oxid Med Cell Longev. 2015;2015: 482582. https:\/\/doi.org\/10.1155\/2015\/482582.","journal-title":"Oxid Med Cell Longev"},{"key":"473_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biocel.2015.01.026","volume":"63","author":"U Cagin","year":"2015","unstructured":"Cagin U, Enriquez JA. The complex crosstalk between mitochondria and the nucleus: What goes in between? Int J Biochem Cell Biol. 2015;63:10\u20135. https:\/\/doi.org\/10.1016\/j.biocel.2015.01.026.","journal-title":"Int J Biochem Cell Biol"},{"key":"473_CR50","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/febs.13820","volume":"284","author":"C Ploumi","year":"2017","unstructured":"Ploumi C, Daskalaki I, Tavernarakis N. Mitochondrial biogenesis and clearance: a balancing act. FEBS J. 2017;284:183\u201395. https:\/\/doi.org\/10.1111\/febs.13820.","journal-title":"FEBS J"},{"key":"473_CR51","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1146\/annurev-genet-110410-132529","volume":"46","author":"DC Chan","year":"2012","unstructured":"Chan DC. Fusion and fission: interlinked processes critical for mitochondrial health. Annu Rev Genet. 2012;46:265\u201387. https:\/\/doi.org\/10.1146\/annurev-genet-110410-132529.","journal-title":"Annu Rev Genet"},{"key":"473_CR52","doi-asserted-by":"publisher","first-page":"iv","DOI":"10.1016\/j.semcancer.2017.10.013","volume":"47","author":"K Singh","year":"2017","unstructured":"Singh K, Modica-napolitano J. Special issue: mitochondria in cancer. Semin Cancer Biol. 2017;47:iv\u2013vi. https:\/\/doi.org\/10.1016\/j.semcancer.2017.10.013.","journal-title":"Semin Cancer Biol"},{"key":"473_CR53","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/ng1341","volume":"36","author":"S Zuchner","year":"2004","unstructured":"Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, Zappia M, Nelis E, Patitucci A, Senderek J, Parman Y, Evgrafov O, Jonghe PD, Takahashi Y, Tsuji S, Pericak-Vance MA, Quattrone A, Battaloglu E, Polyakov AV, Timmerman V, Schroder JM, Vance JM. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet. 2004;36:449\u201351. https:\/\/doi.org\/10.1038\/ng1341.","journal-title":"Nat Genet"},{"key":"473_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/79944","volume":"26","author":"C Alexander","year":"2000","unstructured":"Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A, Rodriguez M, Kellner U, Leo-Kottler B, Auburger G, Bhattacharya SS, Wissinger B. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet. 2000;26:211\u20135. https:\/\/doi.org\/10.1038\/79944.","journal-title":"Nat Genet"},{"key":"473_CR55","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/79936","volume":"26","author":"C Delettre","year":"2000","unstructured":"Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, Astarie-Dequeker C, Lasquellec L, Arnaud B, Ducommun B, Kaplan J, Hamel CP. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000;26:207\u201310. https:\/\/doi.org\/10.1038\/79936.","journal-title":"Nat Genet"},{"key":"473_CR56","doi-asserted-by":"publisher","first-page":"R169","DOI":"10.1093\/hmg\/ddp326","volume":"18","author":"H Chen","year":"2009","unstructured":"Chen H, Chan DC. Mitochondrial dynamics\u2013fusion, fission, movement, and mitophagy\u2013in neurodegenerative diseases. Hum Mol Genet. 2009;18:R169\u201376. https:\/\/doi.org\/10.1093\/hmg\/ddp326.","journal-title":"Hum Mol Genet"},{"key":"473_CR57","doi-asserted-by":"publisher","unstructured":"Singh KK and Modica-Napolitano JS.\u00a0Special Issue: Mitochondria in Cancer. Semin Cancer Biol. 2017;47:iv-vi.\u00a0https:\/\/doi.org\/10.1016\/j.semcancer.2017.10.013","DOI":"10.1016\/j.semcancer.2017.10.013"},{"key":"473_CR58","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mito.2013.10.006","volume":"16","author":"P Govindaraj","year":"2014","unstructured":"Govindaraj P, Khan NA, Rani B, Rani DS, Selvaraj P, Jyothi V, Bahl A, Narasimhan C, Rakshak D, Premkumar K, Khullar M, Thangaraj K. Mitochondrial DNA variations associated with hypertrophic cardiomyopathy. Mitochondrion. 2014;16:65\u201372. https:\/\/doi.org\/10.1016\/j.mito.2013.10.006.","journal-title":"Mitochondrion"},{"key":"473_CR59","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/1947601913476949","volume":"4","author":"HJ Weir","year":"2013","unstructured":"Weir HJ, Lane JD, Balthasar N. SIRT3: a central regulator of mitochondrial adaptation in health and disease. Genes Cancer. 2013;4:118\u201324. https:\/\/doi.org\/10.1177\/1947601913476949.","journal-title":"Genes Cancer"},{"key":"473_CR60","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.mrrev.2015.01.001","volume":"764","author":"MW van Gisbergen","year":"2015","unstructured":"van Gisbergen MW, Voets AM, Starmans MH, de Coo IF, Yadak R, Hoffmann RF, Boutros PC, Smeets HJ, Dubois L, Lambin P. How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models. Mutat Res Rev Mutat Res. 2015;764:16\u201330. https:\/\/doi.org\/10.1016\/j.mrrev.2015.01.001.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"473_CR61","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.lfs.2017.11.019","volume":"192","author":"AH de Mello","year":"2018","unstructured":"de Mello AH, Costa AB, Engel JDG, Rezin GT. Mitochondrial dysfunction in obesity. Life Sci. 2018;192:26\u201332. https:\/\/doi.org\/10.1016\/j.lfs.2017.11.019.","journal-title":"Life Sci"},{"key":"473_CR62","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.tem.2012.06.004","volume":"23","author":"CM Kusminski","year":"2012","unstructured":"Kusminski CM, Scherer PE. Mitochondrial dysfunction in white adipose tissue. Trends Endocrinol Metab. 2012;23:435\u201343. https:\/\/doi.org\/10.1016\/j.tem.2012.06.004.","journal-title":"Trends Endocrinol Metab"},{"key":"473_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117633","volume":"252","author":"K Song","year":"2020","unstructured":"Song K, Zhang Y, Ga Q, Bai Z, Ge RL. High-altitude chronic hypoxia ameliorates obesity-induced non-alcoholic fatty liver disease in mice by regulating mitochondrial and AMPK signaling. Life Sci. 2020;252: 117633. https:\/\/doi.org\/10.1016\/j.lfs.2020.117633.","journal-title":"Life Sci"},{"key":"473_CR64","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11154-016-9339-2","volume":"17","author":"M Nati","year":"2016","unstructured":"Nati M, Haddad D, Birkenfeld AL, Koch CA, Chavakis T, Chatzigeorgiou A. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). Rev Endocr Metab Disord. 2016;17:29\u201339. https:\/\/doi.org\/10.1007\/s11154-016-9339-2.","journal-title":"Rev Endocr Metab Disord"},{"key":"473_CR65","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nature04634","volume":"440","author":"N Houstis","year":"2006","unstructured":"Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440:944\u20138. https:\/\/doi.org\/10.1038\/nature04634.","journal-title":"Nature"},{"key":"473_CR66","doi-asserted-by":"publisher","first-page":"E209","DOI":"10.1210\/jc.2013-3042","volume":"99","author":"X Yin","year":"2014","unstructured":"Yin X, Lanza IR, Swain JM, Sarr MG, Nair KS, Jensen MD. Adipocyte mitochondrial function is reduced in human obesity independent of fat cell size. J Clin Endocrinol Metab. 2014;99:E209\u201316. https:\/\/doi.org\/10.1210\/jc.2013-3042.","journal-title":"J Clin Endocrinol Metab"},{"key":"473_CR67","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1079\/bjn2003000968","volume":"90","author":"S Iossa","year":"2003","unstructured":"Iossa S, Lionetti L, Mollica MP, Crescenzo R, Botta M, Barletta A, Liverini G. Effect of high-fat feeding on metabolic efficiency and mitochondrial oxidative capacity in adult rats. Br J Nutr. 2003;90:953\u201360. https:\/\/doi.org\/10.1079\/bjn2003000968.","journal-title":"Br J Nutr"},{"key":"473_CR68","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/oby.2008.10","volume":"16","author":"C Raffaella","year":"2008","unstructured":"Raffaella C, Francesca B, Italia F, Marina P, Giovanna L, Susanna I. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance. Obesity (Silver Spring). 2008;16:958\u201364. https:\/\/doi.org\/10.1038\/oby.2008.10.","journal-title":"Obesity (Silver Spring)"},{"key":"473_CR69","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1042\/BJ20080868","volume":"417","author":"SK Mantena","year":"2009","unstructured":"Mantena SK, Vaughn DP, Andringa KK, Eccleston HB, King AL, Abrams GA, Doeller JE, Kraus DW, Darley-Usmar VM, Bailey SM. High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem J. 2009;417:183\u201393. https:\/\/doi.org\/10.1042\/BJ20080868.","journal-title":"Biochem J"},{"key":"473_CR70","doi-asserted-by":"publisher","first-page":"E731","DOI":"10.1152\/ajpendo.00159.2011","volume":"302","author":"MH Holmstrom","year":"2012","unstructured":"Holmstrom MH, Iglesias-Gutierrez E, Zierath JR, Garcia-Roves PM. Tissue-specific control of mitochondrial respiration in obesity-related insulin resistance and diabetes. Am J Physiol Endocrinol Metab. 2012;302:E731\u20139. https:\/\/doi.org\/10.1152\/ajpendo.00159.2011.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"473_CR71","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.metabol.2013.04.001","volume":"62","author":"MH Holmstrom","year":"2013","unstructured":"Holmstrom MH, Tom RZ, Bjornholm M, Garcia-Roves PM, Zierath JR. Effect of leptin treatment on mitochondrial function in obese leptin-deficient ob\/ob mice. Metabolism. 2013;62:1258\u201367. https:\/\/doi.org\/10.1016\/j.metabol.2013.04.001.","journal-title":"Metabolism"},{"key":"473_CR72","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1210\/jc.2009-1590","volume":"94","author":"A Fleischman","year":"2009","unstructured":"Fleischman A, Kron M, Systrom DM, Hrovat M, Grinspoon SK. Mitochondrial function and insulin resistance in overweight and normal-weight children. J Clin Endocrinol Metab. 2009;94:4923\u201330. https:\/\/doi.org\/10.1210\/jc.2009-1590.","journal-title":"J Clin Endocrinol Metab"},{"key":"473_CR73","doi-asserted-by":"publisher","first-page":"E49","DOI":"10.1152\/ajpendo.00317.2009","volume":"298","author":"VB Ritov","year":"2010","unstructured":"Ritov VB, Menshikova EV, Azuma K, Wood R, Toledo FG, Goodpaster BH, Ruderman NB, Kelley DE. Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am J Physiol Endocrinol Metab. 2010;298:E49-58. https:\/\/doi.org\/10.1152\/ajpendo.00317.2009.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"473_CR74","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1128\/MCB.05603-11","volume":"32","author":"HF Jheng","year":"2012","unstructured":"Jheng HF, Tsai PJ, Guo SM, Kuo LH, Chang CS, Su IJ, Chang CR, Tsai YS. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol Cell Biol. 2012;32:309\u201319. https:\/\/doi.org\/10.1128\/MCB.05603-11.","journal-title":"Mol Cell Biol"},{"key":"473_CR75","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1073\/pnas.0511154103","volume":"103","author":"T Yu","year":"2006","unstructured":"Yu T, Robotham JL, Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci U S A. 2006;103:2653\u20138. https:\/\/doi.org\/10.1073\/pnas.0511154103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"473_CR76","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1042\/bj2310439","volume":"231","author":"LJ Brady","year":"1985","unstructured":"Brady LJ, Brady PS, Romsos DR, Hoppel CL. Elevated hepatic mitochondrial and peroxisomal oxidative capacities in fed and starved adult obese (ob\/ob) mice. Biochem J. 1985;231:439\u201344. https:\/\/doi.org\/10.1042\/bj2310439.","journal-title":"Biochem J"},{"key":"473_CR77","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/s0026-0495(99)90124-5","volume":"48","author":"FM Ferreira","year":"1999","unstructured":"Ferreira FM, Palmeira CM, Seica R, Santos MS. Alterations of liver mitochondrial bioenergetics in diabetic Goto-Kakizaki rats. Metabolism. 1999;48:1115\u20139. https:\/\/doi.org\/10.1016\/s0026-0495(99)90124-5.","journal-title":"Metabolism"},{"key":"473_CR78","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1439-0396.2007.00752.x","volume":"92","author":"P Nguyen","year":"2008","unstructured":"Nguyen P, Leray V, Diez M, Serisier S, Le Bloc\u2019h J, Siliart B, Dumon H. Liver lipid metabolism. J Anim Physiol Anim Nutr (Berl). 2008;92:272\u201383. https:\/\/doi.org\/10.1111\/j.1439-0396.2007.00752.x.","journal-title":"J Anim Physiol Anim Nutr (Berl)"},{"key":"473_CR79","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75:3313\u201327. https:\/\/doi.org\/10.1007\/s00018-018-2860-6.","journal-title":"Cell Mol Life Sci"},{"key":"473_CR80","doi-asserted-by":"publisher","first-page":"E384","DOI":"10.1152\/ajpendo.00226.2010","volume":"299","author":"A Falcon","year":"2010","unstructured":"Falcon A, Doege H, Fluitt A, Tsang B, Watson N, Kay MA, Stahl A. FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase. Am J Physiol Endocrinol Metab. 2010;299:E384\u201393. https:\/\/doi.org\/10.1152\/ajpendo.00226.2010.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"473_CR81","doi-asserted-by":"publisher","first-page":"22186","DOI":"10.1074\/jbc.M803510200","volume":"283","author":"H Doege","year":"2008","unstructured":"Doege H, Grimm D, Falcon A, Tsang B, Storm TA, Xu H, Ortegon AM, Kazantzis M, Kay MA, Stahl A. Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia. J Biol Chem. 2008;283:22186\u201392. https:\/\/doi.org\/10.1074\/jbc.M803510200.","journal-title":"J Biol Chem"},{"key":"473_CR82","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1210\/en.2015-1866","volume":"157","author":"CG Wilson","year":"2016","unstructured":"Wilson CG, Tran JL, Erion DM, Vera NB, Febbraio M, Weiss EJ. Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice. Endocrinology. 2016;157:570\u201385. https:\/\/doi.org\/10.1210\/en.2015-1866.","journal-title":"Endocrinology"},{"key":"473_CR83","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cmet.2012.01.004","volume":"15","author":"IW Asterholm","year":"2012","unstructured":"Asterholm IW, Mundy DI, Weng J, Anderson RG, Scherer PE. Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1. Cell Metab. 2012;15:171\u201385. https:\/\/doi.org\/10.1016\/j.cmet.2012.01.004.","journal-title":"Cell Metab"},{"key":"473_CR84","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","volume":"136","author":"S Kersten","year":"2017","unstructured":"Kersten S, Stienstra R. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver. Biochimie. 2017;136:75\u201384. https:\/\/doi.org\/10.1016\/j.biochi.2016.12.019.","journal-title":"Biochimie"},{"key":"473_CR85","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.ajpath.2015.01.018","volume":"185","author":"Q Gao","year":"2015","unstructured":"Gao Q, Jia Y, Yang G, Zhang X, Boddu PC, Petersen B, Narsingam S, Zhu Y-J, Thimmapaya B, Kanwar YS, Reddy JK. PPAR\u03b1-deficient ob\/ob obese mice become more obese and manifest severe hepatic steatosis due to decreased fatty acid oxidation. Am J Pathol. 2015;185:1396\u2013408. https:\/\/doi.org\/10.1016\/j.ajpath.2015.01.018.","journal-title":"Am J Pathol"},{"key":"473_CR86","doi-asserted-by":"publisher","first-page":"17075","DOI":"10.1073\/pnas.0707060104","volume":"104","author":"D Zhang","year":"2007","unstructured":"Zhang D, Liu ZX, Choi CS, Tian L, Kibbey R, Dong J, Cline GW, Wood PA, Shulman GI. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci U S A. 2007;104:17075\u201380. https:\/\/doi.org\/10.1073\/pnas.0707060104.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"473_CR87","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/brv.12178","volume":"91","author":"FW Sanders","year":"2016","unstructured":"Sanders FW, Griffin JL. De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose. Biol Rev Camb Philos Soc. 2016;91:452\u201368. https:\/\/doi.org\/10.1111\/brv.12178.","journal-title":"Biol Rev Camb Philos Soc"},{"key":"473_CR88","doi-asserted-by":"publisher","first-page":"9520","DOI":"10.1074\/jbc.M111421200","volume":"277","author":"G Liang","year":"2002","unstructured":"Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS. Diminished hepatic response to fasting\/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem. 2002;277:9520\u20138. https:\/\/doi.org\/10.1074\/jbc.M111421200.","journal-title":"J Biol Chem"},{"key":"473_CR89","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","volume":"134","author":"E Fabbrini","year":"2008","unstructured":"Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology. 2008;134:424\u201331. https:\/\/doi.org\/10.1053\/j.gastro.2007.11.038.","journal-title":"Gastroenterology"},{"key":"473_CR90","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2337\/db06-0200","volume":"55","author":"R Dentin","year":"2006","unstructured":"Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob\/ob mice. Diabetes. 2006;55:2159\u201370. https:\/\/doi.org\/10.2337\/db06-0200.","journal-title":"Diabetes"},{"key":"473_CR91","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","volume":"152","author":"Z Chen","year":"2020","unstructured":"Chen Z, Tian R, She Z, Cai J, Li H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med. 2020;152:116\u201341. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.02.025.","journal-title":"Free Radic Biol Med"},{"key":"473_CR92","doi-asserted-by":"publisher","unstructured":"Iozzo P, Bucci M, Roivainen A, Nagren K, Jarvisalo MJ, Kiss J, Guiducci L, Fielding B, Naum AG, Borra R, Virtanen K, Savunen T, Salvadori PA, Ferrannini E, Knuuti J and Nuutila P. Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals. Gastroenterology. 2010;139:846\u201356, 856 e1\u20136.\u00a0https:\/\/doi.org\/10.1053\/j.gastro.2010.05.039","DOI":"10.1053\/j.gastro.2010.05.039"},{"key":"473_CR93","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.3748\/wjg.v26.i17.1993","volume":"26","author":"A Katsarou","year":"2020","unstructured":"Katsarou A, Moustakas II, Pyrina I, Lembessis P, Koutsilieris M, Chatzigeorgiou A. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease. World J Gastroenterol. 2020;26:1993\u20132011. https:\/\/doi.org\/10.3748\/wjg.v26.i17.1993.","journal-title":"World J Gastroenterol"},{"key":"473_CR94","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.tem.2019.08.006","volume":"30","author":"Z Chen","year":"2019","unstructured":"Chen Z, Yu Y, Cai J, Li H. Emerging molecular targets for treatment of nonalcoholic fatty liver disease. Trends Endocrinol Metab. 2019;30:903\u201314. https:\/\/doi.org\/10.1016\/j.tem.2019.08.006.","journal-title":"Trends Endocrinol Metab"},{"key":"473_CR95","doi-asserted-by":"publisher","first-page":"8591","DOI":"10.3390\/ijms15058591","volume":"15","author":"W Peverill","year":"2014","unstructured":"Peverill W, Powell LW, Skoien R. Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci. 2014;15:8591\u2013638. https:\/\/doi.org\/10.3390\/ijms15058591.","journal-title":"Int J Mol Sci"},{"key":"473_CR96","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/hep.30834","volume":"71","author":"A-M Papatheodoridi","year":"2020","unstructured":"Papatheodoridi A-M, Chrysavgis L, Koutsilieris M, Chatzigeorgiou A. The role of senescence in the development of nonalcoholic fatty liver disease and progression to nonalcoholic steatohepatitis. Hepatology. 2020;71:363\u201374. https:\/\/doi.org\/10.1002\/hep.30834.","journal-title":"Hepatology"},{"key":"473_CR97","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.3390\/ijms22073446","volume":"22","author":"II Moustakas","year":"2021","unstructured":"Moustakas II, Katsarou A, Legaki A-I, Pyrina I, Ntostoglou K, Papatheodoridi A-M, Gercken B, Pateras IS, Gorgoulis VG, Koutsilieris M, Chavakis T, Chatzigeorgiou A. Hepatic senescence accompanies the development of NAFLD in non-aged mice independently of obesity. Int J Mol Sci. 2021;22:3446. https:\/\/doi.org\/10.3390\/ijms22073446.","journal-title":"Int J Mol Sci"},{"key":"473_CR98","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/path.4803","volume":"240","author":"S Sookoian","year":"2016","unstructured":"Sookoian S, Flichman D, Scian R, Rohr C, Dopazo H, Gianotti TF, Martino JS, Casta\u00f1o GO, Pirola CJ. Mitochondrial genome architecture in non-alcoholic fatty liver disease. J Pathol. 2016;240:437\u201349. https:\/\/doi.org\/10.1002\/path.4803.","journal-title":"J Pathol"},{"key":"473_CR99","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s11901-016-0302-1","volume":"15","author":"J Wattacheril","year":"2016","unstructured":"Wattacheril J, Sanyal AJ. Lean NAFLD: an underrecognized outlier. Curr Hepatol Rep. 2016;15:134\u20139. https:\/\/doi.org\/10.1007\/s11901-016-0302-1.","journal-title":"Curr Hepatol Rep"},{"key":"473_CR100","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jhep.2008.05.016","volume":"49","author":"M Komatsu","year":"2008","unstructured":"Komatsu M, Yazaki M, Tanaka N, Sano K, Hashimoto E, Takei Y, Song YZ, Tanaka E, Kiyosawa K, Saheki T, Aoyama T, Kobayashi K. Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease. J Hepatol. 2008;49:810\u201320. https:\/\/doi.org\/10.1016\/j.jhep.2008.05.016.","journal-title":"J Hepatol"},{"key":"473_CR101","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jhep.2019.01.036","volume":"70","author":"A Hakim","year":"2019","unstructured":"Hakim A, Zhang X, DeLisle A, Oral EA, Dykas D, Drzewiecki K, Assis DN, Silveira M, Batisti J, Jain D, Bale A, Mistry PK, Vilarinho S. Clinical utility of genomic analysis in adults with idiopathic liver disease. J Hepatol. 2019;70:1214\u201321. https:\/\/doi.org\/10.1016\/j.jhep.2019.01.036.","journal-title":"J Hepatol"},{"key":"473_CR102","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.127737","author":"JA Fletcher","year":"2019","unstructured":"Fletcher JA, Deja S, Satapati S, Fu X, Burgess SC, Browning JD. Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver. JCI Insight. 2019. https:\/\/doi.org\/10.1172\/jci.insight.127737.","journal-title":"JCI Insight"},{"key":"473_CR103","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1089\/ars.2010.3795","volume":"15","author":"EM Morris","year":"2011","unstructured":"Morris EM, Rector RS, Thyfault JP, Ibdah JA. Mitochondria and redox signaling in steatohepatitis. Antioxid Redox Signal. 2011;15:485\u2013504. https:\/\/doi.org\/10.1089\/ars.2010.3795.","journal-title":"Antioxid Redox Signal"},{"key":"473_CR104","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","volume":"21","author":"C Koliaki","year":"2015","unstructured":"Koliaki C, Szendroedi J, Kaul K, Jelenik T, Nowotny P, Jankowiak F, Herder C, Carstensen M, Krausch M, Knoefel WT, Schlensak M, Roden M. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 2015;21:739\u201346. https:\/\/doi.org\/10.1016\/j.cmet.2015.04.004.","journal-title":"Cell Metab"},{"key":"473_CR105","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/joim.13147","volume":"289","author":"CJ Pirola","year":"2021","unstructured":"Pirola CJ, Garaycoechea M, Flichman D, Casta\u00f1o GO, Sookoian S. Liver mitochondrial DNA damage and genetic variability of cytochrome b \u2013 a key component of the respirasome \u2013 drive the severity of fatty liver disease. J Intern Med. 2021;289:84\u201396. https:\/\/doi.org\/10.1111\/joim.13147.","journal-title":"J Intern Med"},{"key":"473_CR106","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1074\/jbc.274.9.5692","volume":"274","author":"KD Chavin","year":"1999","unstructured":"Chavin KD, Yang S, Lin HZ, Chatham J, Chacko VP, Hoek JB, Walajtys-Rode E, Rashid A, Chen CH, Huang CC, Wu TC, Lane MD, Diehl AM. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem. 1999;274:5692\u2013700. https:\/\/doi.org\/10.1074\/jbc.274.9.5692.","journal-title":"J Biol Chem"},{"key":"473_CR107","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3945\/ajcn.115.107599","volume":"102","author":"M Fritsch","year":"2015","unstructured":"Fritsch M, Koliaki C, Livingstone R, Phielix E, Bierwagen A, Meisinger M, Jelenik T, Strassburger K, Zimmermann S, Brockmann K, Wolff C, Hwang JH, Szendroedi J, Roden M. Time course of postprandial hepatic phosphorus metabolites in lean, obese, and type 2 diabetes patients. Am J Clin Nutr. 2015;102:1051\u20138. https:\/\/doi.org\/10.3945\/ajcn.115.107599.","journal-title":"Am J Clin Nutr"},{"key":"473_CR108","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/hep.23093","volume":"50","author":"J Szendroedi","year":"2009","unstructured":"Szendroedi J, Chmelik M, Schmid AI, Nowotny P, Brehm A, Krssak M, Moser E, Roden M. Abnormal hepatic energy homeostasis in type 2 diabetes. Hepatology. 2009;50:1079\u201386. https:\/\/doi.org\/10.1002\/hep.23093.","journal-title":"Hepatology"},{"key":"473_CR109","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1194\/jlr.M023382","volume":"53","author":"S Satapati","year":"2012","unstructured":"Satapati S, Sunny NE, Kucejova B, Fu X, He TT, Mendez-Lucas A, Shelton JM, Perales JC, Browning JD, Burgess SC. Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J Lipid Res. 2012;53:1080\u201392. https:\/\/doi.org\/10.1194\/jlr.M023382.","journal-title":"J Lipid Res"},{"key":"473_CR110","doi-asserted-by":"publisher","first-page":"E484","DOI":"10.1152\/ajpendo.00492.2015","volume":"310","author":"RE Patterson","year":"2016","unstructured":"Patterson RE, Kalavalapalli S, Williams CM, Nautiyal M, Mathew JT, Martinez J, Reinhard MK, McDougall DJ, Rocca JR, Yost RA, Cusi K, Garrett TJ, Sunny NE. Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity. Am J Physiol Endocrinol Metab. 2016;310:E484\u201394. https:\/\/doi.org\/10.1152\/ajpendo.00492.2015.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"473_CR111","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.mito.2020.12.010","volume":"57","author":"S Ajaz","year":"2021","unstructured":"Ajaz S, McPhail MJ, Gnudi L, Trovato FM, Mujib S, Napoli S, Carey I, Agarwal K. Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD). Mitochondrion. 2021;57:119\u201330. https:\/\/doi.org\/10.1016\/j.mito.2020.12.010.","journal-title":"Mitochondrion"},{"key":"473_CR112","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.cell.2007.08.047","volume":"131","author":"JA Pospisilik","year":"2007","unstructured":"Pospisilik JA, Knauf C, Joza N, Benit P, Orthofer M, Cani PD, Ebersberger I, Nakashima T, Sarao R, Neely G, Esterbauer H, Kozlov A, Kahn CR, Kroemer G, Rustin P, Burcelin R, Penninger JM. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell. 2007;131:476\u201391. https:\/\/doi.org\/10.1016\/j.cell.2007.08.047.","journal-title":"Cell"},{"key":"473_CR113","doi-asserted-by":"publisher","first-page":"15066","DOI":"10.1073\/pnas.232591499","volume":"99","author":"A Wredenberg","year":"2002","unstructured":"Wredenberg A, Wibom R, Wilhelmsson H, Graff C, Wiener HH, Burden SJ, Oldfors A, Westerblad H, Larsson N-G. Increased mitochondrial mass in mitochondrial myopathy mice. Proc Natl Acad Sci. 2002;99:15066\u201371. https:\/\/doi.org\/10.1073\/pnas.232591499.","journal-title":"Proc Natl Acad Sci"},{"key":"473_CR114","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.cmet.2012.10.016","volume":"16","author":"C Vernochet","year":"2012","unstructured":"Vernochet C, Mourier A, Bezy O, Macotela Y, Boucher J, Rardin Matthew J, An D, Lee Kevin Y, Ilkayeva Olga R, Zingaretti Cristina M, Emanuelli B, Smyth G, Cinti S, Newgard Christopher B, Gibson Bradford W, Larsson N-G, Kahn CR. Adipose-specific deletion of tfam increases mitochondrial oxidation and protects mice against obesity and insulin resistance. Cell Metab. 2012;16:765\u201376. https:\/\/doi.org\/10.1016\/j.cmet.2012.10.016.","journal-title":"Cell Metab"},{"key":"473_CR115","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/hep4.1271","volume":"2","author":"C Garc\u00eda-Ruiz","year":"2018","unstructured":"Garc\u00eda-Ruiz C, Fern\u00e1ndez-Checa JC. Mitochondrial oxidative stress and antioxidants balance in fatty liver disease. Hepatology communications. 2018;2:1425\u201339. https:\/\/doi.org\/10.1002\/hep4.1271.","journal-title":"Hepatology communications"},{"key":"473_CR116","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/s0016-5085(99)70022-3","volume":"116","author":"H Cortez-Pinto","year":"1999","unstructured":"Cortez-Pinto H, Zhi Lin H, Qi Yang S, Odwin Da Costa S, Diehl AM. Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes. Gastroenterology. 1999;116:1184\u201393. https:\/\/doi.org\/10.1016\/s0016-5085(99)70022-3.","journal-title":"Gastroenterology"},{"key":"473_CR117","doi-asserted-by":"publisher","first-page":"G868","DOI":"10.1152\/ajpgi.00179.2013","volume":"305","author":"EM Morris","year":"2013","unstructured":"Morris EM, Jackman MR, Meers GM, Johnson GC, Lopez JL, MacLean PS, Thyfault JP. Reduced hepatic mitochondrial respiration following acute high-fat diet is prevented by PGC-1alpha overexpression. Am J Physiol Gastrointest Liver Physiol. 2013;305:G868\u201380. https:\/\/doi.org\/10.1152\/ajpgi.00179.2013.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"473_CR118","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/gut.2007.147496","volume":"57","author":"G Serviddio","year":"2008","unstructured":"Serviddio G, Bellanti F, Tamborra R, Rollo T, Capitanio N, Romano AD, Sastre J, Vendemiale G, Altomare E. Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury. Gut. 2008;57:957\u201365. https:\/\/doi.org\/10.1136\/gut.2007.147496.","journal-title":"Gut"},{"key":"473_CR119","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/jama.282.17.1659","volume":"282","author":"H Cortez-Pinto","year":"1999","unstructured":"Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA. 1999;282:1659\u201364. https:\/\/doi.org\/10.1001\/jama.282.17.1659.","journal-title":"JAMA"},{"key":"473_CR120","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.molcel.2016.02.022","volume":"61","author":"E Schrepfer","year":"2016","unstructured":"Schrepfer E, Scorrano L. Mitofusins, from mitochondria to metabolism. Mol Cell. 2016;61:683\u201394. https:\/\/doi.org\/10.1016\/j.molcel.2016.02.022.","journal-title":"Mol Cell"},{"key":"473_CR121","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/sj.emboj.7601963","volume":"27","author":"G Twig","year":"2008","unstructured":"Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, Shirihai OS. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 2008;27:433\u201346. https:\/\/doi.org\/10.1038\/sj.emboj.7601963.","journal-title":"EMBO J"},{"key":"473_CR122","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/hep.22183","volume":"47","author":"Z Li","year":"2008","unstructured":"Li Z, Berk M, McIntyre TM, Gores GJ, Feldstein AE. The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology. 2008;47:1495\u2013503. https:\/\/doi.org\/10.1002\/hep.22183.","journal-title":"Hepatology"},{"key":"473_CR123","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.yexcr.2009.12.008","volume":"316","author":"L Zhang","year":"2010","unstructured":"Zhang L, Seitz LC, Abramczyk AM, Chan C. Synergistic effect of cAMP and palmitate in promoting altered mitochondrial function and cell death in HepG2 cells. Exp Cell Res. 2010;316:716\u201327. https:\/\/doi.org\/10.1016\/j.yexcr.2009.12.008.","journal-title":"Exp Cell Res"},{"key":"473_CR124","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1007\/s00125-021-05488-2","volume":"64","author":"Y Takeichi","year":"2021","unstructured":"Takeichi Y, Miyazawa T, Sakamoto S, Hanada Y, Wang L, Gotoh K, Uchida K, Katsuhara S, Sakamoto R, Ishihara T, Masuda K, Ishihara N, Nomura M, Ogawa Y. Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor. Diabetologia. 2021;64:2092\u2013107. https:\/\/doi.org\/10.1007\/s00125-021-05488-2.","journal-title":"Diabetologia"},{"key":"473_CR125","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1073\/pnas.1108220109","volume":"109","author":"D Sebastian","year":"2012","unstructured":"Sebastian D, Hernandez-Alvarez MI, Segales J, Sorianello E, Munoz JP, Sala D, Waget A, Liesa M, Paz JC, Gopalacharyulu P, Oresic M, Pich S, Burcelin R, Palacin M, Zorzano A. Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc Natl Acad Sci U S A. 2012;109:5523\u20138. https:\/\/doi.org\/10.1073\/pnas.1108220109.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"473_CR126","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2019.04.010","volume":"177","author":"MI Hern\u00e1ndez-Alvarez","year":"2019","unstructured":"Hern\u00e1ndez-Alvarez MI, Sebasti\u00e1n D, Vives S, Ivanova S, Bartoccioni P, Kakimoto P, Plana N, Veiga SR, Hern\u00e1ndez V, Vasconcelos N, Peddinti G, Adrover A, Jov\u00e9 M, Pamplona R, Gordaliza-Alaguero I, Calvo E, Cabr\u00e9 N, Castro R, Kuzmanic A, Boutant M, Sala D, Hyotylainen T, Ore\u0161i\u010d M, Fort J, Errasti-Murugarren E, Rodr\u00edgues CMP, Orozco M, Joven J, Cant\u00f3 C, Palacin M, Fern\u00e1ndez-Veledo S, Vendrell J, Zorzano A. Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease. Cell. 2019;177:881-895.e17. https:\/\/doi.org\/10.1016\/j.cell.2019.04.010.","journal-title":"Cell"},{"key":"473_CR127","doi-asserted-by":"publisher","first-page":"17190","DOI":"10.1074\/jbc.M212754200","volume":"278","author":"D Bach","year":"2003","unstructured":"Bach D, Pich S, Soriano FX, Vega N, Baumgartner B, Oriola J, Daugaard JR, Lloberas J, Camps M, Zierath JR, Rabasa-Lhoret R, Wallberg-Henriksson H, Laville M, Palacin M, Vidal H, Rivera F, Brand M, Zorzano A. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem. 2003;278:17190\u20137. https:\/\/doi.org\/10.1074\/jbc.M212754200.","journal-title":"J Biol Chem"},{"key":"473_CR128","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mito.2014.03.012","volume":"15","author":"IO Goncalves","year":"2014","unstructured":"Goncalves IO, Passos E, Rocha-Rodrigues S, Diogo CV, Torrella JR, Rizo D, Viscor G, Santos-Alves E, Marques-Aleixo I, Oliveira PJ, Ascensao A, Magalhaes J. Physical exercise prevents and mitigates non-alcoholic steatohepatitis-induced liver mitochondrial structural and bioenergetics impairments. Mitochondrion. 2014;15:40\u201351. https:\/\/doi.org\/10.1016\/j.mito.2014.03.012.","journal-title":"Mitochondrion"},{"key":"473_CR129","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","volume":"14","author":"NE Sunny","year":"2011","unstructured":"Sunny NE, Parks EJ, Browning JD, Burgess SC. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 2011;14:804\u201310. https:\/\/doi.org\/10.1016\/j.cmet.2011.11.004.","journal-title":"Cell Metab"},{"key":"473_CR130","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1053\/j.gastro.2010.05.039","volume":"139","author":"P Iozzo","year":"2010","unstructured":"Iozzo P, Bucci M, Roivainen A, N\u00e5gren K, J\u00e4rvisalo MJ, Kiss J, Guiducci L, Fielding B, Naum AG, Borra R, Virtanen K, Savunen T, Salvadori PA, Ferrannini E, Knuuti J, Nuutila P. Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals. Gastroenterology. 2010;139:846-856.e6. https:\/\/doi.org\/10.1053\/j.gastro.2010.05.039.","journal-title":"Gastroenterology"},{"key":"473_CR131","doi-asserted-by":"publisher","unstructured":"Leveille M and Estall JL.\u00a0Mitochondrial dysfunction in the Transition from NASH to HCC. 2019;9. https:\/\/doi.org\/10.3390\/metabo9100233","DOI":"10.3390\/metabo9100233"},{"key":"473_CR132","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.2337\/diabetes.54.5.1392","volume":"54","author":"I Bogacka","year":"2005","unstructured":"Bogacka I, Xie H, Bray GA, Smith SR. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes. 2005;54:1392\u20139. https:\/\/doi.org\/10.2337\/diabetes.54.5.1392.","journal-title":"Diabetes"},{"key":"473_CR133","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/obr.12163","volume":"15","author":"A Chatzigeorgiou","year":"2014","unstructured":"Chatzigeorgiou A, Kandaraki E, Papavassiliou AG, Koutsilieris M. Peripheral targets in obesity treatment: a comprehensive update. Obes Rev. 2014;15:487\u2013503. https:\/\/doi.org\/10.1111\/obr.12163.","journal-title":"Obes Rev"},{"key":"473_CR134","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bcp.2018.11.020","volume":"160","author":"I Grattagliano","year":"2019","unstructured":"Grattagliano I, Montezinho LP, Oliveira PJ, Fruhbeck G, Gomez-Ambrosi J, Montecucco F, Carbone F, Wieckowski MR, Wang DQ, Portincasa P. Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease. Biochem Pharmacol. 2019;160:34\u201345. https:\/\/doi.org\/10.1016\/j.bcp.2018.11.020.","journal-title":"Biochem Pharmacol"},{"issue":"1511\u20131523","key":"473_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.09.070","volume":"29","author":"Y Wang","year":"2019","unstructured":"Wang Y, An H, Liu T, Qin C, Sesaki H, Guo S, Radovick S, Hussain M, Maheshwari A, Wondisford FE, O\u2019Rourke B, He L. Metformin improves mitochondrial respiratory activity through activation of AMPK. Cell Rep. 2019;29(1511\u20131523): e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.09.070.","journal-title":"Cell Rep"},{"key":"473_CR136","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/CIRCRESAHA.107.165472","volume":"102","author":"J-a Kim","year":"2008","unstructured":"Kim J-a, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res. 2008;102:401\u201314. https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.165472.","journal-title":"Circ Res"},{"key":"473_CR137","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.atherosclerosis.2009.01.026","volume":"206","author":"MS Rosselli","year":"2009","unstructured":"Rosselli MS, Burgue\u00f1o AL, Carabelli J, Schuman M, Pirola CJ, Sookoian S. Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model. Atherosclerosis. 2009;206:119\u201326. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.01.026.","journal-title":"Atherosclerosis"},{"key":"473_CR138","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.redox.2018.10.019","volume":"20","author":"J Bi","year":"2019","unstructured":"Bi J, Zhang J, Ren Y, Du Z, Li Q, Wang Y, Wei S, Yang L, Zhang J, Liu C, Lv Y, Wu R. Irisin alleviates liver ischemia-reperfusion injury by inhibiting excessive mitochondrial fission, promoting mitochondrial biogenesis and decreasing oxidative stress. Redox Biol. 2019;20:296\u2013306. https:\/\/doi.org\/10.1016\/j.redox.2018.10.019.","journal-title":"Redox Biol"},{"key":"473_CR139","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1111\/bph.14212","volume":"175","author":"JW Kang","year":"2018","unstructured":"Kang JW, Choi HS, Lee SM. Resolvin D1 attenuates liver ischaemia\/reperfusion injury through modulating thioredoxin 2-mediated mitochondrial quality control. Br J Pharmacol. 2018;175:2441\u201353. https:\/\/doi.org\/10.1111\/bph.14212.","journal-title":"Br J Pharmacol"},{"key":"473_CR140","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1038\/s41467-020-16991-2","volume":"11","author":"L Barbier-Torres","year":"2020","unstructured":"Barbier-Torres L, Fortner KA, Iruzubieta P, Delgado TC, Giddings E, Chen Y, Champagne D, Fernandez-Ramos D, Mestre D, Gomez-Santos B, Varela-Rey M, de Juan VG, Fernandez-Tussy P, Zubiete-Franco I, Garcia-Monzon C, Gonzalez-Rodriguez A, Oza D, Valenca-Pereira F, Fang Q, Crespo J, Aspichueta P, Tremblay F, Christensen BC, Anguita J, Martinez-Chantar ML, Rincon M. Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation. Nat Commun. 2020;11:3360. https:\/\/doi.org\/10.1038\/s41467-020-16991-2.","journal-title":"Nat Commun"},{"key":"473_CR141","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neulet.2012.12.049","volume":"535","author":"N Zhang","year":"2013","unstructured":"Zhang N, Wang S, Li Y, Che L, Zhao Q. A selective inhibitor of Drp1, mdivi-1, acts against cerebral ischemia\/reperfusion injury via an anti-apoptotic pathway in rats. Neurosci Lett. 2013;535:104\u20139. https:\/\/doi.org\/10.1016\/j.neulet.2012.12.049.","journal-title":"Neurosci Lett"},{"key":"473_CR142","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/15376516.2019.1669247","volume":"30","author":"M Hasnat","year":"2020","unstructured":"Hasnat M, Yuan Z, Ullah A, Naveed M, Raza F, Baig M, Khan A, Xu D, Su Y, Sun L, Zhang L, Jiang Z. Mitochondria-dependent apoptosis in triptolide-induced hepatotoxicity is associated with the Drp1 activation. Toxicol Mech Methods. 2020;30:124\u201333. https:\/\/doi.org\/10.1080\/15376516.2019.1669247.","journal-title":"Toxicol Mech Methods"},{"key":"473_CR143","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00395-018-0684-z","volume":"113","author":"MV Basalay","year":"2018","unstructured":"Basalay MV, Davidson SM, Gourine AV, Yellon DM. Neural mechanisms in remote ischaemic conditioning in the heart and brain: mechanistic and translational aspects. Basic Res Cardiol. 2018;113:25. https:\/\/doi.org\/10.1007\/s00395-018-0684-z.","journal-title":"Basic Res Cardiol"}],"container-title":["Current Obesity Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-022-00473-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13679-022-00473-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-022-00473-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T05:54:19Z","timestamp":1661234059000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13679-022-00473-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":143,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["473"],"URL":"https:\/\/doi.org\/10.1007\/s13679-022-00473-1","relation":{},"ISSN":["2162-4968"],"issn-type":[{"value":"2162-4968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"26 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have read and approved the final manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}